Clinical Trial Update: A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Resistant Potato Starch to reduce musculoskeletal symptoms associated with aromatase inhibitor therapy in people with early-stage breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Resistant Potato Starch (Resistant potato starch)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Status: RECRUITING